MedPath

Reliantheart Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation

Not Applicable
Terminated
Conditions
Congestive Heart Failure
Heart Failure
Cardiac Failure
Heart Failure, Left-sided
Interventions
Device: Control VAD
Device: HeartAssist 5® VAD System
First Posted Date
2014-07-31
Last Posted Date
2018-07-18
Lead Sponsor
ReliantHeart Inc.
Target Recruit Count
17
Registration Number
NCT02205411
Locations
🇺🇸

University of California San Francisco, San Francisco, California, United States

🇺🇸

University of Stanford, Stanford, California, United States

🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

and more 11 locations
© Copyright 2025. All Rights Reserved by MedPath